Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Measurement Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Identifying research questions for HIV, tuberculosis, tuberculosis-HIV, malaria, and neglected tropical diseases through the World Health Organization guideline development process: a retrospective analysis, 2008-2018.

Hargreaves S, Himmels J, Nellums L, et al. Public health. 2020;
Download PDF
Publication

Village Response to Mass Drug Administration for Schistosomiasis in Mwanza Region, Northwestern Tanzania: Are We Missing Socioeconomic, Cultural, and Political Dimensions?

Mwanga JR, Kinung’hi SM, Mosha J, et al. American Society of Tropical Medicine and Hygiene. The American Journal of Tropical Medicine and Hygiene. 2020;
Download PDF
Publication

Accelerating access to medicines in a changing world

Kettler H, Lehtimaki S, Schwalbe N. WHO Press. Bulletin of the World Health Organization. 2020; 98 (9) : 641-643.
Download PDF
Publication

Experience of Persons Affected by Leprosy in Facing Psychosocial Problems: A Qualitative Method

Yusuf A, Aditya RS, Yunitasari E, et al. Systematic Reviews in Pharmacy. 2020; 11 (7) : 219-223.
Download PDF
Publication

Schisto and Ladders version 2: a health educational board game to support compliance with school-based mass drug administration with praziquantel – a pilot study

Ejike CU, Oluwole AS, Omitola OO, et al. Oxford University Press (OUP). International Health. 2020;
Publication

‘Review: Broader Health Impacts of Vertical Responses to COVID-19 in Low- and Middle-income Countries

Hrynick H, Ripoll S, Carter S. Social Science in Humanitarian Action (SSHAP) . 2020;
Download PDF
Publication

Neglected Tropical Diseases and Other Infectious Diseases Affecting the Heart. The NET-Heart Project: Rationale and Design

Burgos LM, Farina J, Liendro MC, et al. Ubiquity Press, Ltd.. Global Heart. 2020;
Download PDF
Publication

When to replicate systematic reviews of interventions: consensus checklist

Tugwell P, Welch V, Karunananthan S, et al. BMJ. BMJ. 2020;
Download PDF
Publication

From leprosy to COVID-19, how stigma makes it harder to fight epidemics

Chandrashekhar V. American Association for the Advancement of Science. 2020;
Download PDF
Publication

Awareness of Indian medical practitioners about snakebite and its management – Is there a need to re-evaluate medical training?

Chatterjee K, Malik A. Medknow. Medical Journal of Dr. D.Y. Patil Vidyapeeth. 2020; 13 (5) : 519.
Download PDF

Pagination

  • Previous page ‹ ‹ Previous
  • …
  • Page 494
  • Page 495
  • Page 496
  • Page 497
  • Current page 498
  • Page 499
  • Page 500
  • Page 501
  • Page 502
  • …
  • Next page Next › ›
  • Last page Last » »
Subscribe to

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2026 InfoNTD